Riskli Bebek İzlemi
Özet
Riskli bebek takibi, gebelik ve doğum sürecindeki sorunlar nedeniyle nörogelişimsel açıdan risk altındaki bebeklerin erken tanılanması, tedavi edilmesi ve rehabilitasyonunu kapsamaktadır. Prematürite, enfeksiyonlar ve hipoksik iskemik ensefalopati gibi faktörlerin yol açtığı gelişimsel sorunların yönetimi için multidisipliner bir izlem protokolü ve bireyselleştirilmiş erken müdahale programları hayati önem taşımaktadır. Erken dönemde uygulanan tarama testleri ve rehabilitasyon yaklaşımları, çocuğun fonksiyonel bağımsızlığını ve yaşam kalitesini artırarak uzun vadeli engellilik oranlarını düşürmeyi hedeflemektedir.
Follow-up of high-risk infants involves the early diagnosis, treatment, and rehabilitation of newborns at risk for neurodevelopmental delays due to complications during pregnancy or childbirth. Managing developmental issues caused by factors such as prematurity, infections, and hypoxic-ischemic encephalopathy requires multidisciplinary monitoring protocols and individualized early intervention programs. Early screening tests and rehabilitation approaches aim to enhance functional independence and quality of life while reducing long-term disability rates.
Referanslar
Walker K, Holland AJ, Halliday R, Badawi N. Which high-risk infants should we follow-up and how should we do it? J Paediatr Child Health. 2012 Sep;48:789-93.
Vasudevan P, Suri M. A clinical approach to developmental delay and intellectual disability. Clin Med (Lond). 2017 Dec;17:558-561.
Sher EH, Shevell MI. Global developmental delay an intellectual disability. In: Swaiman K F (ed). Swaiman’s pediatric neurology sixth edition. Edinburg: Elsevier saunders, 2017:1007-1028.
Houtrow AJ, Larson K, Olson LM, Newacheck PW, Halfon N. Changing trends of childhood disability, 2001-2011. Pediatrics. 2014 Sep;134:530-8.
World Health Organization 2018. Preterm birth. http://www.who.int/en/news-room/factsheets/detail/preterm-birth (accessed on June 15, 2021)
WHO, March of Dimes, PMNCH, Save the Children. 15 million preterm births: Priorities for action based on national, regional and global estimates. In: Howson CP, Kinney MV, Lawn J, eds. Born Too Soon: The Global Action Report on Preterm Birth. 2012.
Marlow N, Wolke D, Bracewell MA, Samara M; EPICure Study Group. Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med. 2005 Jan 6;352:9-19.
Ancel PY, Livinec F, Larroque B, Marret S, Arnaud C, Pierrat V, et al. EPIPAGE Study Group. Cerebral palsy among very preterm children in relation to gestational age and neonatal ultrasound abnormalities: the EPIPAGE cohort study. Pediatrics. 2006 Mar;117:828-35.
Beaino G, Khoshnood B, Kaminski M, Pierrat V, Marret S, Matis J, et al. EPIPAGE Study Group. Predictors of cerebral palsy in very preterm infants: the EPIPAGE prospective population-based cohort study. Dev Med Child Neurol. 2010 Jun;52:e119-25.
Volpe JJ. Intracranial hemorrhage: Germinal matrix-Intraventricular hemorrhage of the premature infant. In neurology of the newborn (Ed Volpe JJ). Fifth edition. Philadelphia:WB Saunders Company; 2008; 517-588.
Ment LR, Bada HS, Barnes P, Grant PE, Hirtz D, Papile LA, et al. Practice parameter: neuroimaging of the neonate: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2002 Jun 25;58:1726-38.
Yıldız EP, Ekici B, Tatlı B. Neonatal hypoxic ischemic encephalopathy: an update on disease pathogenesis and treatment. Expert Rev Neurother. 2017 May;17:449-459.
Akısü M, Kumral A, Canpolat FE. Türk neonatoloji derneği, neonatal ensefalopati tanı ve tedavi rehberi, 2018.
Gencpınar P, Tüzün F, Ozbal S, Tuğyan K, Duman N, Ozkan H, et al. Effects of neotrofin on neonatal hypoxic ischemic brain injury. Neurosci Lett. 2011 Nov 14;505:205-10.
Tüzün F, Gencpınar P, Ozbal S, Dilek M, Ergur BU, Duman N, t al. Neuroprotective effect of neotrofin in a neonatal rat model of periventricular leukomalacia. Neurosci Lett. 2012 Jun 27;520:6-10.
Gamaleldin R, Iskander I, Seoud I, Aboraya H, Aravkin A, Sampson PD, et al. Risk factors for neurotoxicity in newborns with severe neonatal hyperbilirubinemia. Pediatrics. 2011 Oct;128:e925-31.
Donneborg ML, Hansen BM, Vandborg PK, Rodrigo-Domingo M, Ebbesen F. Extreme neonatal hyperbilirubinemia and kernicterus spectrum disorder in Denmark during the years 2000-2015. J Perinatol. 2020 Feb;40:194-202.
Wisnowski JL, Panigrahy A, Painter MJ, Watchko JF. Magnetic Resonance Imaging Abnormalities in Advanced Acute Bilirubin Encephalopathy Highlight Dentato-Thalamo-Cortical Pathways. J Pediatr. 2016 Jul;174:260-3.
American Academy of Pediatrics. Follow-up care of high-risk infants. Pediartics 2004:114:1377.
Acunaş B, Uslu S, Baş AY. Turkish Neonatal Society guideline for the follow-up of high-risk newborn infants. Turk Pediatri Ars. 2018 Dec 25;53:180-195.
Swaiman K F. Phillips J. Neurologic examination after the newborn period until 2 years of age. In: Swaiman K F (ed). Swaiman’s pediatric neurology sixth edition. Edinburg: Elsevier saunders, 2017: 39-48.
Piper MC, Pinnell LE, Darrah J, Maguire T, Byrne PJ. Construction and validation of the Alberta Infant Motor Scale (AIMS). Can J Public Health. 1992 Jul-Aug;83:46-50.
Yıldırım ZH, Aydınlı N, Ekici B, Tatlı B, Calişkan M. Can Alberta infant motor scale and milani comparetti motor development screening test be rapid alternatives to bayley scales of infant development-II at high-risk infants. Ann Indian Acad Neurol. 2012 Jul;15:196-9.
Campbell SK, Kolobe TH, Osten ET, Lenke M, Girolami GL. Construct validity of the test of infant motor performance. Phys Ther. 1995 Jul;75:585-96.
Peyton C, Schreiber MD, Msall ME. The Test of Infant Motor Performance at 3 months predicts language, cognitive, and motor outcomes in infants born preterm at 2 years of age. Dev Med Child Neurol. 2018 Dec;60:1239-1243.
http://gcn.org.tr/tr/denver-ii-test. Erişim tarihi: 2 Mayıs 2021
Denver II Gelişmsel tarama testi ‘Türkiye Standardizasyonu’. Kalbiye Yalaz, Banu Anlar, Birgül U. Bayoğlu, Gellişimsel Çocuk Nörolojisi Derneği, Ankara, 2010.
Hallioglu O, Topaloglu AK, Zenciroglu A, Duzovali O, Yilgor E, Saribas S. Denver developmental screening test II for early identification of the infants who will develop major neurological deficit as a sequalea of hypoxic-ischemic encephalopathy. Pediatr Int. 2001 Aug;43:400-4.
Sezgin N. Ankara Gelişim Tarama Envanteri AGTE için iki farklı geçerlik çalışması: ölçüte bağlı ve eş zamanlı ayırdedici geçerliği. Turk J Child Adolesc Ment Health 2011;18:185-196.
Bayley, N. (2006). Bayley scales of infant and toddler development, third edition: Administration manual. San Antonio, TX: Harcourt.
Flynn RS, Huber MD, DeMauro SB. Predictive Value of the BSID-II and the Bayley-III for Early School Age Cognitive Function in Very Preterm Infants. Glob Pediatr Health. 2020 Nov 20;7:2333794X20973146.
Prechtl HF, Einspieler C, Cioni G, Bos AF, Ferrari F, Sontheimer D. An early marker for neurological deficits after perinatal brain lesions. Lancet. 1997 May 10;349:1361-3.
Flynn RS, Huber MD, DeMauro SB. Predictive Value of the BSID-II and the Bayley-III for Early School Age Cognitive Function in Very Preterm Infants. Glob Pediatr Health. 2020 Nov 20;7:2333794X20973146.
Folio MR, Fewell RR. PDMS-2 Peabody developmental motor scales second edition. Austin: PRO-ED Inc. 2000.
American Academy of Pediatrics, Joint Committee on Infant Hearing. Year 2007 position statement: Principles and guidelines for early hearing detection and intervention programs. Pediatrics 2007:120:898.
Türkiye Cumhuriyeti Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü Ulusal Yenidoğan İşitme Taraması Uygulama Rehberi, 2017
American Academy of Pediatrics, American Academy of Ophthalmology; American Association for Pediatrics Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2013; 131:189-195.
Koc E, Bas AY, Özdek Ş, Ovalı F, Başmak H, TOD ROP Komisyonu, TND ROP Çalışma Grubu. Türkiye Prematüre Retinopatisi Rehberi 2016.
Kerem Günel M. Pediatrik Fizyoterapi ve Rehabilitasyon Uygulamalarında Nörogelişimsel Tedavi Yaklaşımı. Türkiye Klinikleri Fiziksel Tıp ve Rehabilitasyon - Özel Konular. 2010;3:1-7.
Akhbari Ziegler S, von Rhein M, Meichtry A, Wirz M, Hielkema T, Hadders-Algra M; Swiss Neonatal Network & Follow-Up Group. The Coping with and Caring for Infants with Special Needs intervention was associated with improved motor development in preterm infants. Acta Paediatr. 2021 Apr;110:1189-1200.
Naylor CE, Bower E. Modified constraint-induced movement therapy for young children with hemiplegic cerebral palsy: a pilot study. Dev Med Child Neurol. 2005 Jun;47:365-9.
Gülten Erkin, Canan Aybay, Aydan Kurtaran, Aytül Çakçı, Yavuz Gürer. Serebral Palsi riski taşıyan infantların vojta yöntemi ile tanınması ve tedavisi. Fiziksel Tıp ve Rehabilitasyon Bilimleri Dergisi. 2004. Cilt 7 sayı 3.
Section On Complementary And Integrative Medicine; Council on Children with Disabilities; American Academy of Pediatrics, Zimmer M, Desch L. Sensory integration therapies for children with developmental and behavioral disorders. Pediatrics. 2012 Jun;129:1186-9.
Eva Brogren Carlberg, Kristina Löwing. Serebral Palsili Çocuklarda Hedefe Yönelik Tedavi. Türkiye Klinikleri Fiziksel Tıp ve Rehabilitasyon - Özel Konular. 2010;3(3):53-7.
